| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
* Center for Experimental Therapeutics and Reperfusion Injury, Brigham and Women’s Hospital and Harvard Medical School, Department of Oral Medicine, Infection and Immunity, Harvard School of Dental Medicine, Boston, Massachusetts, USA;
Cardiovascular Division, King’s College, New Hunt’s House, Guy’s Campus, London, UK;
Division of Immunity and Infection, MRC Center for Immune Regulation, University of Birmingham Medical School, Edgbaston, UK;
Centre for Clinical Pharmacology and Therapeutics, Division of Medicine, University College London, London, UK;
|| University of Edinburgh, MRC/Centre for Inflammation Research, The Queen’s Medical Research Institute, Edinburgh, UK;
¶ School of Biochemistry and Immunology, Trinity College Dublin, Ireland;
** William Harvey Research Institute, Queen Mary University of London, Charterhouse Square, London, UK;
Inflammation Research Network, University of Calgary, Calgary, Alberta, Canada
1Correspondence: Center for Experimental Therapeutics and Reperfusion Injury, Brigham and Women’s Hospital and Harvard Medical School, Department of Oral Medicine, Infection and Immunity, Harvard School of Dental Medicine, 75 Francis St., Thorn 724, Boston, MA, USA 02115. E-mail: cnserhan{at}zeus.bwh.harvard.edu
A recent focus meeting on Controlling Acute Inflammation was held in London, April 27–28, 2006, organized by D.W. Gilroy and S.D. Brain for the British Pharmacology Society. We concluded at the meeting that a consensus report was needed that addresses the rapid progress in this emerging field and details how the specific study of resolution of acute inflammation provides leads for novel anti-inflammatory therapeutics, as well as defines the terms and key components of interest in the resolution process within tissues as appreciated today. The inflammatory response protects the body against infection and injury but can itself become dysregulated with deleterious consequences to the host. It is now evident that endogenous biochemical pathways activated during defense reactions can counter-regulate inflammation and promote resolution. Hence, resolution is an active rather than a passive process, as once believed, which now promises novel approaches for the treatment of inflammation-associated diseases based on endogenous agonists of resolution.—Serhan, C. N., Brain, S. D., Buckley, C. D., Gilroy, D. W., Haslett, C., O’Neill, L. A. J., Perretti, M., Rossi, A. G., Wallace, J. L. Resolution of inflammation: state of the art, definitions and terms.
Key Words: anti-inflammatories • leukocytes • lipid mediators • chemokines • cytokines
This article has been cited by other articles:
|
|
 |
|
  L. Piqueras, M. J. Sanz, M. Perretti, E. Morcillo, L. Norling, J. A. Mitchell, Y. Li, and D. Bishop-Bailey Activation of PPAR{beta}/{delta} inhibits leukocyte recruitment, cell adhesion molecule expression, and chemokine release J. Leukoc. Biol., July 1, 2009; 86(1): 115 - 122. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. P. Kataru, K. Jung, C. Jang, H. Yang, R. A. Schwendener, J. E. Baik, S. H. Han, K. Alitalo, and G. Y. Koh Critical role of CD11b+ macrophages and VEGF in inflammatory lymphangiogenesis, antigen clearance, and inflammation resolution Blood, May 28, 2009; 113(22): 5650 - 5659. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. V Norling, M. Perretti, and D. Cooper Endogenous galectins and the control of the host inflammatory response J. Endocrinol., May 1, 2009; 201(2): 169 - 184. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. B. Zurier, Y.-P. Sun, K. L. George, J. A. Stebulis, R. G. Rossetti, A. Skulas, E. Judge, and C. N. Serhan Ajulemic acid, a synthetic cannabinoid, increases formation of the endogenous proresolving and anti-inflammatory eicosanoid, lipoxin A4 FASEB J, May 1, 2009; 23(5): 1503 - 1509. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Michlewska, I. Dransfield, I. L. Megson, and A. G. Rossi Macrophage phagocytosis of apoptotic neutrophils is critically regulated by the opposing actions of pro-inflammatory and anti-inflammatory agents: key role for TNF-{alpha} FASEB J, March 1, 2009; 23(3): 844 - 854. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Haniffa, M. P. Collin, C. D. Buckley, and F. Dazzi Mesenchymal stem cells: the fibroblasts' new clothes? Haematologica, February 1, 2009; 94(2): 258 - 263. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Whelan Dietary Stearidonic Acid Is a Long Chain (n-3) Polyunsaturated Fatty Acid with Potential Health Benefits J. Nutr., January 1, 2009; 139(1): 5 - 10. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. Panzer, G. Zahner, U. Wienberg, O. M. Steinmetz, A. Peters, J.-E. Turner, H.-J. Paust, G. Wolf, R. A. K. Stahl, and A. Schneider 15-Deoxy-{Delta}12,14-prostaglandin J2 inhibits INF-{gamma}-induced JAK/STAT1 signalling pathway activation and IP-10/CXCL10 expression in mesangial cells Nephrol. Dial. Transplant., December 1, 2008; 23(12): 3776 - 3785. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Leoni, H. B. Patel, A. L. F. Sampaio, F. N. E. Gavins, J. F. Murray, P. Grieco, S. J. Getting, and M. Perretti Inflamed phenotype of the mesenteric microcirculation of melanocortin type 3 receptor-null mice after ischemia-reperfusion FASEB J, December 1, 2008; 22(12): 4228 - 4238. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Bystrom, I. Evans, J. Newson, M. Stables, I. Toor, N. van Rooijen, M. Crawford, P. Colville-Nash, S. Farrow, and D. W. Gilroy Resolution-phase macrophages possess a unique inflammatory phenotype that is controlled by cAMP Blood, November 15, 2008; 112(10): 4117 - 4127. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Johansson-Haque, E. Palanichamy, and S. Okret Stimulation of MAPK-phosphatase 1 gene expression by glucocorticoids occurs through a tethering mechanism involving C/EBP J. Mol. Endocrinol., October 1, 2008; 41(4): 239 - 249. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Wallace Prostaglandins, NSAIDs, and Gastric Mucosal Protection: Why Doesn't the Stomach Digest Itself? Physiol Rev, October 1, 2008; 88(4): 1547 - 1565. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Dalli, L. V. Norling, D. Renshaw, D. Cooper, K.-Y. Leung, and M. Perretti Annexin 1 mediates the rapid anti-inflammatory effects of neutrophil-derived microparticles Blood, September 15, 2008; 112(6): 2512 - 2519. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Erridge, S. Kennedy, C. M. Spickett, and D. J. Webb Oxidized Phospholipid Inhibition of Toll-like Receptor (TLR) Signaling Is Restricted to TLR2 and TLR4: ROLES FOR CD14, LPS-BINDING PROTEIN, AND MD2 AS TARGETS FOR SPECIFICITY OF INHIBITION J. Biol. Chem., September 5, 2008; 283(36): 24748 - 24759. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. S. Machado, L. Esper, A. Dias, R. Madan, Y. Gu, D. Hildeman, C. N. Serhan, C. L. Karp, and J. Aliberti Native and aspirin-triggered lipoxins control innate immunity by inducing proteasomal degradation of TRAF6 J. Exp. Med., May 12, 2008; 205(5): 1077 - 1086. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Kim, S. Wilcox-Adelman, Y. Sano, W.-J. Tang, R. J. Collier, and J. M. Park From the Cover: Antiinflammatory cAMP signaling and cell migration genes co-opted by the anthrax bacillus PNAS, April 22, 2008; 105(16): 6150 - 6155. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Hong, T. F. Porter, Y. Lu, S. F. Oh, P. S. Pillai, and C. N. Serhan Resolvin E1 Metabolome in Local Inactivation during Inflammation-Resolution J. Immunol., March 1, 2008; 180(5): 3512 - 3519. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Gronert Lipid Autacoids in Inflammation and Injury Responses: A Matter of Privilege Mol. Interv., February 1, 2008; 8(1): 28 - 35. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T.-T. Hong, J. Huang, T. D. Barrett, and B. R. Lucchesi Effects of cyclooxygenase inhibition on canine coronary artery blood flow and thrombosis Am J Physiol Heart Circ Physiol, January 1, 2008; 294(1): H145 - H155. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Hasturk, A. Kantarci, E. Goguet-Surmenian, A. Blackwood, C. Andry, C. N. Serhan, and T. E. Van Dyke Resolvin E1 Regulates Inflammation at the Cellular and Tissue Level and Restores Tissue Homeostasis In Vivo J. Immunol., November 15, 2007; 179(10): 7021 - 7029. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Haworth and B. D. Levy Endogenous lipid mediators in the resolution of airway inflammation Eur. Respir. J., November 1, 2007; 30(5): 980 - 992. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Abe, K. P. Nguyen, S. D. Fine, J.-H. Mo, C. Shen, S. Shenouda, M. Corr, S. Jung, J. Lee, L. Eckmann, et al. Conventional dendritic cells regulate the outcome of colonic inflammation independently of T cells PNAS, October 23, 2007; 104(43): 17022 - 17027. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Wada, C. J. DeLong, Y. H. Hong, C. J. Rieke, I. Song, R. S. Sidhu, C. Yuan, M. Warnock, A. H. Schmaier, C. Yokoyama, et al. Enzymes and Receptors of Prostaglandin Pathways with Arachidonic Acid-derived Versus Eicosapentaenoic Acid-derived Substrates and Products J. Biol. Chem., August 3, 2007; 282(31): 22254 - 22266. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. P Holt and D. H Adams Complex roles of cyclo-oxygenase 2 in hepatitis Gut, July 1, 2007; 56(7): 903 - 904. [Full Text] [PDF]
|
|
|
|
 |
|
 L.-P. Erwig and P. M. Henson Immunological Consequences of Apoptotic Cell Phagocytosis Am. J. Pathol., July 1, 2007; 171(1): 2 - 8. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
